Justine P.
- Country
- France
- Department
- service de dermatologie
Research Overview
- Evaluation of Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Amlitelimab in Patients with Moderate to Severe Atopic Dermatitis from Previous Trials
- Phase 3 Study on the Safety and Efficacy of Upadacitinib Versus Dupilumab in Pediatric Patients Aged 2-12 with Moderate to Severe Atopic Dermatitis
- Efficacy and Safety Evaluation of Subcutaneous Amlitelimab in Moderate-to-Severe Atopic Dermatitis with Background Topical Corticosteroids in Adolescents and Adults
Data & Insights
Has run more than one trial at 116 of 273 partner sites.
Specializations
Atopic Dermatitis Management
The investigator specializes in treating moderate to severe atopic dermatitis, with particular emphasis on innovative therapeutic approaches for patients who have had inadequate responses to conventional treatments.
- Novel Biologic Therapies
- Pediatric Atopic Dermatitis Treatment
- Long-term Disease Management
Their research extends to evaluating treatment strategies for patients aged 2 years and older, including specialized approaches for atopic hand eczema.
Urticaria Research
The investigator focuses on advanced treatments for various forms of urticaria, including chronic spontaneous urticaria and chronic inducible urticaria.
- Antihistamine-Resistant Cases
- Novel Treatment Protocols
- Long-term Disease Control
Their expertise includes managing complex cases such as symptomatic dermographism, cold urticaria, and cholinergic urticaria.
Specialized Dermatological Conditions
The investigator has expertise in treating severe erythema multiforme and other challenging dermatological conditions requiring hospital-based management.
- Acute Phase Treatment
- Hospital-Based Care
- Pain Management Protocols
Their work encompasses both immediate intervention strategies and long-term therapeutic approaches for severe dermatological conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.